Anacor Pharmaceuticals, Inc. (ANAC) Reports First Quarter 2013 Financial Results
5/10/2013 7:40:56 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Announces First Quarter 2013 Financial Results Conference Call and Webcast
5/8/2013 7:45:47 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Prices $20 Million Public Offering of Common Stock
4/26/2013 10:01:22 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Signs $17.7 Million Research Agreement With the Bill & Melinda Gates Foundation
4/8/2013 9:00:43 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) to Hold Conference Call Tomorrow, March 21, 2013 at 8am ET / 5am PT to Discuss Preliminary Results From the Phase 2 Dose-Ranging Study of AN2728 in the Treatment of Adolescents With Atopic Dermatitis
3/21/2013 11:23:02 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Reports 2012 Fourth Quarter and Year-End Financial Results
3/15/2013 6:24:38 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Reveals Positive Data From Second Phase-3 Trial of Tavaborole
3/1/2013 7:06:25 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) to Present at the Cowen and Company 33rdAnnual Healthcare Conference
2/26/2013 6:44:41 AM
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Falls on Positive But Disappointing Toenail Fungus Data
1/29/2013 6:49:38 AM
More...
|
Anacor Pharmaceuticals, Inc. Co-Founder Lucy Shapiro Awarded National Medal of Science
1/18/2013 9:13:11 AM
More...
|
|